Literature DB >> 14709805

Evolved regulation of gonadotropin-releasing hormone receptor cell surface expression.

Jo Ann Janovick1, Alfredo Ulloa-Aguirre, P Michael Conn.   

Abstract

Dominant negative effects of mutant gonadotropin-releasing hormone (GnRH) receptors (GnRHR; isolated from patients with idiopathic hypogonadotropic hypogonadism) on plasma membrane expression (PME) and function of the wt GnRHR were examined. In addition, we assessed the effect of mutants on wt GnRHR with receptor modifications that, by themselves, diminished PME. Among such mechanisms that restrict PME of GnRHR in primates are: (a) addition of the primate-specific K191 and (b) deletion of the carboxyl tail ("Ctail") found in pre-mammalian species (fish, birds) of GnRHR. We prepared rat (r) and human (h) GnRHR plasmids (88% homologous), each with or without the K191; chimeras were then made with C-tail or each of four truncated fragments (selected to isolate consensus sites for palmitoylation or phosphorylation) of the 51-amino-acid Ser-rich piscine GnRHR C-tail and then expressed in COS-7 cells. The data suggest that the dominant negative effect of the mutants on the hGnRHR requires intrinsic low PME that co-evolved with the dominant-negative effect. The data further reveal that additional modifications must have occurred in primates that are important for both the diminution of the PME and the development of the dominant negative effect of the mutants.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14709805     DOI: 10.1385/ENDO:22:3:317

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  51 in total

Review 1.  Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function.

Authors:  Stephane Angers; Ali Salahpour; Michel Bouvier
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

2.  The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3-D3nf interaction causes mislocalization of D3 receptors.

Authors:  K D Karpa; R Lin; N Kabbani; R Levenson
Journal:  Mol Pharmacol       Date:  2000-10       Impact factor: 4.436

3.  Measurement of changes in fluorescence resonance energy transfer between gonadotropin-releasing hormone receptors in response to agonists.

Authors:  Anda Cornea; P Michael Conn
Journal:  Methods       Date:  2002-08       Impact factor: 3.608

4.  N-glycosylation in expression and function of beta-adrenergic receptors.

Authors:  S T George; A E Ruoho; C C Malbon
Journal:  J Biol Chem       Date:  1986-12-15       Impact factor: 5.157

5.  Complete hypogonadotropic hypogonadism associated with a novel inactivating mutation of the gonadotropin-releasing hormone receptor.

Authors:  F P Pralong; F Gomez; E Castillo; S Cotecchia; L Abuin; M L Aubert; L Portmann; R C Gaillard
Journal:  J Clin Endocrinol Metab       Date:  1999-10       Impact factor: 5.958

6.  Dominant-negative action of disease-causing gonadotropin-releasing hormone receptor (GnRHR) mutants: a trait that potentially coevolved with decreased plasma membrane expression of GnRHR in humans.

Authors:  Alfredo Leaños-Miranda; Alfredo Ulloa-Aguirre; Tae H Ji; Jo Ann Janovick; P Michael Conn
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

7.  Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic target.

Authors:  Jo Ann Janovick; Guadalupe Maya-Nunez; P Michael Conn
Journal:  J Clin Endocrinol Metab       Date:  2002-07       Impact factor: 5.958

8.  Potency enhancement of a GnRH agonist: GnRH-receptor microaggregation stimulates gonadotropin release.

Authors:  P M Conn; D C Rogers; R McNeil
Journal:  Endocrinology       Date:  1982-07       Impact factor: 4.736

9.  Identification of the sites of N-linked glycosylation on the human calcium receptor and assessment of their role in cell surface expression and signal transduction.

Authors:  K Ray; P Clapp; P K Goldsmith; A M Spiegel
Journal:  J Biol Chem       Date:  1998-12-18       Impact factor: 5.157

Review 10.  Mutations of the GnRH receptor gene: a new cause of autosomal-recessive hypogonadotropic hypogonadism.

Authors:  M L Kottler; R Counis; P Bouchard
Journal:  Arch Med Res       Date:  1999 Nov-Dec       Impact factor: 2.235

View more
  20 in total

Review 1.  Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptors.

Authors:  Alfredo Ulloa-Aguirre; P Michael Conn
Journal:  Recent Pat Endocr Metab Immune Drug Discov       Date:  2011-01

2.  Rescue of misrouted GnRHR mutants reveals its constitutive activity.

Authors:  Jo Ann Janovick; Irina D Pogozheva; Henry I Mosberg; Anda Cornea; P Michael Conn
Journal:  Mol Endocrinol       Date:  2012-05-17

Review 3.  Trafficking and quality control of the gonadotropin releasing hormone receptor in health and disease.

Authors:  P Michael Conn; Jo Ann Janovick
Journal:  Mol Cell Endocrinol       Date:  2008-11-18       Impact factor: 4.102

Review 4.  Mutations in G protein-coupled receptors that impact receptor trafficking and reproductive function.

Authors:  Alfredo Ulloa-Aguirre; Teresa Zariñán; James A Dias; P Michael Conn
Journal:  Mol Cell Endocrinol       Date:  2013-06-24       Impact factor: 4.102

Review 5.  Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptors.

Authors:  P Michael Conn; Alfredo Ulloa-Aguirre
Journal:  Adv Pharmacol       Date:  2011

6.  Regulation of G-protein coupled receptor traffic by an evolutionary conserved hydrophobic signal.

Authors:  Tim Angelotti; David Daunt; Olga G Shcherbakova; Brian Kobilka; Carl M Hurt
Journal:  Traffic       Date:  2010-01-06       Impact factor: 6.215

7.  The human gonadotropin releasing hormone type I receptor is a functional intracellular GPCR expressed on the nuclear membrane.

Authors:  Michelle Re; Macarena Pampillo; Martin Savard; Céléna Dubuc; Craig A McArdle; Robert P Millar; P Michael Conn; Fernand Gobeil; Moshmi Bhattacharya; Andy V Babwah
Journal:  PLoS One       Date:  2010-07-08       Impact factor: 3.240

8.  Participation of the endoplasmic reticulum protein chaperone thio-oxidoreductase in gonadotropin-releasing hormone receptor expression at the plasma membrane.

Authors:  W Lucca-Junior; J A Janovick; P M Conn
Journal:  Braz J Med Biol Res       Date:  2009-02       Impact factor: 2.590

9.  Mice harboring Gnrhr E90K, a mutation that causes protein misfolding and hypogonadotropic hypogonadism in humans, exhibit testis size reduction and ovulation failure.

Authors:  M David Stewart; Jian Ming Deng; C Allison Stewart; Rachael D Mullen; Ying Wang; Suhujey Lopez; M Katalina Serna; Cheng-Chiu Huang; Jo Ann Janovick; Andrew J Pask; Robert J Schwartz; P Michael Conn; Richard R Behringer
Journal:  Mol Endocrinol       Date:  2012-08-23

10.  Regulation of GPR54 signaling by GRK2 and {beta}-arrestin.

Authors:  Macarena Pampillo; Natasha Camuso; Jay E Taylor; Jacob M Szereszewski; Maryse R Ahow; Mateusz Zajac; Robert P Millar; Moshmi Bhattacharya; Andy V Babwah
Journal:  Mol Endocrinol       Date:  2009-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.